The 6-Plex ProcartaPlex Human Exosomes characterization panel allows simultaneous detection of six protein targets required for the characterization of exosomes with Luminex xMAP technology. In addition, the panel can be used with the...
The 6-Plex ProcartaPlex Human Exosomes characterization panel allows simultaneous detection of six protein targets required for the characterization of exosomes with Luminex xMAP technology. In addition, the panel can be used with the human d-apolipoprotein panel 5 Plex ProcartaPlex (ref. EPX050-15818-901) to determine the nature and purity of dicesomes preparations by analyzing selected protein targets in accordance with the recommendations of the International Society for Extracellular Vesicles (ISEV).
As mediators essential to intercellular communication, exosomes transfer their molecular cargo between cells and have emerged as a new class of biomarkers. Exosomes derived from cancer cells that can contribute to tumour and metastatic processes by shaping the tumour micro-environment and vice versa are recognized as a valuable source of biomarkers, which plays a role in almost all the distinctive signs of cancer.
The panel is supplied in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X, requiring less pipeting and experimental configuration. It cannot be associated with simplexes or other panels.
ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy. ProcartaPlex multiplex panels are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine). They are supplied with the reagents necessary to perform the dosage.
Target list [microbille region]: CD9 [19], CD63 [63], CD81 [35], cytochrome c [54], syntenine-1 [48], VLA-4 [42]
1. Théry C et al. Minimum information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018 7(1):1535750.
About ProcartaPlex strengths for Luminex platform
ProcartaPlex immunoassays are based on the d-ELISA sandwich principles, using two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all protein targets using a Luminex instrument. ProcartaPlex multiplex assays require only 25 µl plasma or serum or 50 µl cell culture supernatant and only four hours to obtain the analyzed results.
• Reproducible and reliable results — validated in panel according to the highest industry standard, including tests for protein compatibility and cross-reactivity
• Plus of results per sample — simultaneously measure multiple protein targets in a single sample of 25 - 50 µl
• Well established Luminex technology highly referenced multiplexing platform for protein detection and quantification
ProcartaPlex assays use Luminex xMAP (multianalyte profiling) technology for simultaneous detection and quantification of up to 80 protein targets in a single 25–50 µl sample — in plasma, serum, cell culture supernatant and other body fluids.
Luminex MagPlex superparamagnetic microspheres in ProcartaPlex are coloured internally with precise proportions of red and infrared fluorophores to create 100 unique signatures that can be identified by Luminex xMAP detection systems (Luminex 200, FLEXMAP 3D and MAGPIX systems). Like the ELISA sandwich assay, ProcartaPlex uses paired antibody pairs to identify the protein of interest. In multiplexed assays, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). The combination of specific antibodies from a protein to a separate microbead allows for the analysis of several targets in a single well.
The most significant difference between a ProcartaPlex assay and a ELISA assay is that the ProcartaPlex capture antibody is combined with a magnetic microbead and is not adsorbed by any of the microplate wells. Thus, ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample. It takes them as long as they do a traditional ELISA sandwich.
ProcartaPlex multiplex panels are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine).